| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $11,691,296 | 12 | 100 |
| Norwalk Leslie V | director | 0 | $0 | 2 | $557,600 | $-557,600 |
| RHOADS ANN D | director | 0 | $0 | 3 | $1.4M | $-1.4M |
| Kline Kyle | Senior Vice President, CFO | 0 | $0 | 2 | $2.03M | $-2.03M |
| ZARRILLI STEPHEN T | director | 0 | $0 | 1 | $2.11M | $-2.11M |
| Davidar David D | director | 0 | $0 | 1 | $2.15M | $-2.15M |
| Huller Kelly | SVP, GC, Corporate Secretary | 0 | $0 | 3 | $3.44M | $-3.44M |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $11.69M worth of Globus Medical, Inc. stock.
On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $0 and sold $17.86M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.
| 2026-02-25 | Sale | Huller Kelly | EVP, GC, Corporate Secretary | 20,000 0.0147% | $94.50 | $1.89M | -3.27% | |
| 2026-02-12 | Sale | Huller Kelly | EVP, GC, Corporate Secretary | 10,000 0.0075% | $87.67 | $876,700 | +3.34% | |
| 2026-01-08 | Sale | Norwalk Leslie V | director | 2,000 0.0016% | $101.10 | $202,200 | -4.02% | |
| 2026-01-08 | Sale | Kline Kyle | Senior Vice President, CFO | 3,594 0.0029% | $101.10 | $363,353 | -4.02% | |
| 2025-12-12 | Sale | Norwalk Leslie V | director | 4,000 0.0031% | $88.85 | $355,400 | +3.99% | |
| 2025-12-01 | Sale | Kline Kyle | Senior Vice President, CFO | 18,542 0.0139% | $90.00 | $1.67M | +0.11% | |
| 2025-11-25 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 7,500 0.0059% | $90.00 | $675,000 | -1.40% | |
| 2025-11-12 | Sale | Davidar David D | director | 25,000 0.019% | $86.00 | $2.15M | +5.51% | |
| 2025-11-11 | Sale | ZARRILLI STEPHEN T | director | 25,000 0.0187% | $84.29 | $2.11M | +5.20% | |
| 2025-11-10 | Sale | RHOADS ANN D | director | 2,000 0.0015% | $85.00 | $170,000 | +3.40% | |
| 2025-11-07 | Sale | RHOADS ANN D | director | 8,000 0.0079% | $81.00 | $648,000 | +6.37% | |
| 2025-09-15 | Sale | RHOADS ANN D | director | 10,000 0.0074% | $58.46 | $584,600 | +50.52% | |
| 2025-02-28 | Sale | RHOADS ANN D | director | 7,500 0.0046% | $78.68 | $590,100 | -21.53% | |
| 2025-01-10 | Sale | Pfeil Keith W | COO, CFO | 14,167 0.0105% | $88.29 | $1.25M | -27.61% | |
| 2024-12-02 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 2,500 0.0019% | $87.00 | $217,502 | -24.87% | |
| 2024-11-22 | Sale | Davidar David D | director | 13,512 0.01% | $85.00 | $1.15M | -25.87% | |
| 2024-11-22 | Sale | Lemaitre Dan | director | 1,097 0.0008% | $85.02 | $93,263 | -25.87% | |
| 2024-11-21 | Sale | Davidar David D | director | 26,488 0.0195% | $85.00 | $2.25M | -25.77% | |
| 2024-11-21 | Sale | Scavilla Daniel T | President, CEO | 130,000 0.0957% | $85.00 | $11.05M | -25.77% | |
| 2024-11-21 | Sale | Lemaitre Dan | director | 13,278 0.0098% | $85.00 | $1.13M | -25.77% |
| Davidar David D | director | 516275 0.3817% | $46.09M | 0 | 24 | |
| RHOADS ANN D | director | 15384 0.0114% | $1.37M | 0 | 5 | |
| Norwalk Leslie V | director | 10419 0.0077% | $930,208.32 | 0 | 4 | |
| ZARRILLI STEPHEN T | director | 0 0% | $0 | 0 | 1 | |
| Huller Kelly | EVP, GC, Corporate Secretary | 0 0% | $0 | 0 | 17 | |
| Kline Kyle | Senior Vice President, CFO | 0 0% | $0 | 0 | 2 | |
| Clarus Lifesciences I, L.P. | 10 percent owner | 7244201 5.356% | $646.76M | 0 | 1 | |
| WHEELER KURT | director | 44319 0.0328% | $3.96M | 0 | 3 | |
| Murphy A Brett | Group President, Commerical Op | 35217 0.026% | $3.14M | 0 | 8 | |
| LIPTAK ROBERT | director | 26159 0.0193% | $2.34M | 0 | 4 | |
| Douglas Robert Andrew | director | 2005 0.0015% | $179,006.40 | 3 | 0 | +25.46% |
| TOBIN JAMES R | 0 0% | $0 | 0 | 7 | ||
| BARON RICHARD A | Senior VP and CFO | 0 0% | $0 | 0 | 1 | |
| Schwartz Eric | Senior VP and General Counsel | 0 0% | $0 | 0 | 2 | |
| Lemaitre Dan | director | 0 0% | $0 | 0 | 5 | |
| Paul David C | Executive Chairman | 0 0% | $0 | 0 | 9 | |
| Demski David M | President, CEO | 0 0% | $0 | 0 | 25 | |
| Payne Steven | Chief Accounting Officer | 0 0% | $0 | 0 | 5 | |
| Williams Anthony L | President | 0 0% | $0 | 0 | 6 | |
| Scavilla Daniel T | President, CEO | 0 0% | $0 | 0 | 6 | |
| Pfeil Keith W | COO, CFO | 0 0% | $0 | 0 | 8 |
| Increased Positions | 280 | +44.59% | 19M | +16.29% |
| Decreased Positions | 283 | -45.06% | 19M | -16.01% |
| New Positions | 123 | New | 5M | New |
| Sold Out Positions | 55 | Sold Out | 5M | Sold Out |
| Total Postitions | 625 | -0.48% | 117M | +0.28% |
| Vanguard Group Inc | $925,882.00 | 9.47% | 10.61M | -103,146 | -0.96% | 2025-09-30 |
| Blackrock, Inc. | $919,559.00 | 9.4% | 10.53M | -230,169 | -2.14% | 2025-09-30 |
| Janus Henderson Group Plc | $659,345.00 | 6.74% | 7.55M | -654,262 | -7.97% | 2025-09-30 |
| Jpmorgan Chase & Co | $321,435.00 | 3.29% | 3.68M | +341,201 | +10.21% | 2025-09-30 |
| Sculptor Capital Lp | $305,550.00 | 3.13% | 3.5M | +739,312 | +26.78% | 2025-09-30 |
| State Street Corp | $302,199.00 | 3.09% | 3.46M | -11,766 | -0.34% | 2025-09-30 |
| Burgundy Asset Management Ltd. | $302,144.00 | 3.09% | 3.46M | -20,455 | -0.59% | 2025-09-30 |
| William Blair Investment Management, Llc | $246,113.00 | 2.52% | 2.82M | +414,134 | +17.22% | 2025-09-30 |
| Madison Avenue Partners, Lp | $222,455.00 | 2.28% | 2.55M | +836,015 | +48.83% | 2025-09-30 |
| Geneva Capital Management Llc | $181,928.00 | 1.86% | 2.08M | +1,151 | +0.06% | 2025-09-30 |